Futura Medical Regulatory News (FUM)

19 May 2016

Name of company:

Futura Medical plc

Name of scheme:

Unapproved Share Option Scheme ("USOS")EMI Share Option Scheme ("EMI")

Period of return:

From:To:

24 November 201519 May 2016

Number and class of securities not issued under the scheme(s)

USOS:EMI:Total:

1,440,6001,394,141

2,834,741

Number of securities issued under the scheme(s) during the period

Number of securities lapsed under the scheme(s) during the period

USOS:EMI:

Nil Nil

USOS:EMI:

Nil (50,000)

Balance under the scheme(s) of securities not yet issued at the end of the period

USOS:EMI:

Total:

1,440,600 1,344,141

2,784,741

Number and class of securities originally admitted and the date of admission

USOS:

USOS Total:

814,424 on 25 May 2011 and 1,202,280 on 8 October 2013

2,016,704

EMI:

EMI Total:

1,520,576 on 25 May 2011 and 1,467,720 on 8 October 20132,988,296

Total:

5,005,000

Name of contact:

Derek Martin, Chief Financial Officer

Telephone number of contact:

+44 (0) 1483 685 670

Futura Medical plc

James Barder, Chief Executive

Tel: +44 (0) 1483 685 670

Email to: james.barder@futuramedical.com

www.futuramedical.com

N+1 Singer (Nominated Adviser and Broker)

Aubrey Powell / Liz Yong / Tom Smale Corporate Finance

Tel:+44 (0) 20 7496 3000

For media enquiries please contact:

Buchanan

Mark Court / Sophie Cowles / Stephanie Watson

Tel: +44 (0) 20 7466 5000